TheStreet Lowers Cardinal Health (NYSE:CAH) to D

TheStreet downgraded shares of Cardinal Health (NYSE:CAH) from a c+ rating to a d rating in a research note released on Thursday, TheStreetRatingsTable reports.

A number of other analysts have also recently commented on the company. Guggenheim set a $55.00 price target on Cardinal Health and gave the company a buy rating in a research note on Thursday, September 12th. Morgan Stanley lowered their price target on Cardinal Health from $50.00 to $41.00 and set an underweight rating for the company in a research note on Friday, September 6th. Argus cut Cardinal Health from a buy rating to a hold rating in a research note on Tuesday, August 27th. Deutsche Bank assumed coverage on Cardinal Health in a research note on Thursday, September 12th. They issued a hold rating and a $50.00 price target for the company. Finally, ValuEngine raised Cardinal Health from a strong sell rating to a sell rating in a research note on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the stock. Cardinal Health has a consensus rating of Hold and a consensus price target of $53.50.

Shares of CAH stock traded up $0.55 on Thursday, reaching $53.75. The company had a trading volume of 3,313,580 shares, compared to its average volume of 2,953,817. The company has a current ratio of 1.07, a quick ratio of 0.54 and a debt-to-equity ratio of 1.20. The stock has a market cap of $15.06 billion, a PE ratio of 10.18, a PEG ratio of 1.72 and a beta of 1.32. The company has a 50-day moving average of $48.75 and a 200-day moving average of $46.39. Cardinal Health has a 12 month low of $41.03 and a 12 month high of $58.31.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.18. The company had revenue of $37.34 billion during the quarter, compared to analysts’ expectations of $36.75 billion. Cardinal Health had a return on equity of 25.96% and a net margin of 0.94%. Cardinal Health’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.29 EPS. Sell-side analysts anticipate that Cardinal Health will post 4.99 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of CAH. Amundi Pioneer Asset Management Inc. increased its stake in Cardinal Health by 19.8% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 317,924 shares of the company’s stock worth $15,307,000 after purchasing an additional 52,482 shares in the last quarter. Swedbank bought a new stake in Cardinal Health during the 2nd quarter worth approximately $106,911,000. Rockland Trust Co. increased its stake in Cardinal Health by 1.4% during the 2nd quarter. Rockland Trust Co. now owns 16,807 shares of the company’s stock worth $792,000 after purchasing an additional 231 shares in the last quarter. Bangor Savings Bank increased its stake in Cardinal Health by 12.5% during the 2nd quarter. Bangor Savings Bank now owns 5,836 shares of the company’s stock worth $275,000 after purchasing an additional 650 shares in the last quarter. Finally, Crossmark Global Holdings Inc. increased its stake in Cardinal Health by 3.5% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 44,692 shares of the company’s stock worth $2,105,000 after purchasing an additional 1,519 shares in the last quarter. 90.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Recommended Story: CBOE Russell 2000® Volatility Index

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Leave a Reply

Your email address will not be published. Required fields are marked *

*